Home > Insider Trading > Filing (0001104659-24-119195)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1425205	Iovance Biotherapeutics Inc.	IOVA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1363984	D Ryan Maynard	C/O Iovance Biotherapeutics, Inc. 825 Industrial Road, 4Th Floor San Carlos CA 94070		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-11-12	50,000	$7.45	57,500	No	4	M	Direct
Common Stock	Disposition	2024-11-12	50,000	$10.06	7,500	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2024-11-12	50,000	$0.00	50,000	$7.45

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2016-02-16	2025-02-15	No	4	M	Direct

Footnotes

Represents an exercise of stock options prior to the 10-year expiration date of such options.
Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $10.05 and $10.105.
These options became exercisable in four equal quarterly installments of 12,500 each following the date of grant, which was February 16, 2015.
Such aggregate number reflects the remainder of such stock options granted on February 16, 2015, but does not include any other stock options held by such Reporting Person.